Twist Bioscience Cash Flow Statement (2017-2026) | TWST

Cash Flow Statement Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-40.04M-41.27M-45.56M-60.67M-60.52M-51.13M-41.82M-59.18M-57.40M-46.24M-43.01M-45.49M-85.58M-34.65M-31.60M-39.35M20.38M-27.12M-30.51M-44.02M
Depreciation and Depletion (Quarter)
3.90M5.70M6.90M7.30M6.90M7.00M7.00M6.40M6.10M6.10M5.80M5.70M5.90M6.10M
Share-based Compensation (Quarter)
9.18M9.25M18.11M22.46M20.04M19.05M-2.33M10.26M10.60M11.75M11.02M13.82M13.73M12.35M11.99M20.33M16.06M16.08M13.27M18.94M
Deferred Taxes (Quarter)
10.54M0.50M0.13M
Gains from Sales and Divestitures (Quarter)
0.06M0.24M0.06M
Gains from Investment Securities (Quarter)
1.71M4.65M1.69M-11.11M-6.14M-0.44M0.05M-0.63M-0.47M-4.86M-0.30M0.64M0.02M-1.36M0.00M-0.00M0.60M-0.60M24.77M-24.77M
Asset Writedowns and Impairment (Quarter)
0.83M1.20M1.17M0.43M0.98M17.53M0.25M0.33M0.45M1.53M0.25M0.26M0.14M0.29M
Non-cash Items (Quarter)
358.15M251.34M148.55M
Cash from Operations (Quarter)
-27.96M-34.80M-46.65M-42.34M-34.12M-1.27M-54.07M-44.29M-23.41M-20.70M-22.97M-19.42M-6.38M-15.32M-21.43M-12.99M-1.40M-11.81M-24.81M-17.56M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.19M1.03M-0.32M-0.47M13.86M1.17M
Depreciation & Amortization (CF) (Quarter)
2.74M2.43M3.15M3.97M4.44M4.95M5.29M7.03M8.49M8.50M8.17M8.30M8.30M6.66M6.38M6.40M6.07M6.00M6.19M6.41M
Change in Working Capital
Change in Receivables (Quarter)
0.58M0.29M2.03M1.81M6.44M-0.66M4.10M3.95M-5.54M1.81M-8.06M0.66M-4.00M2.95M4.54M10.72M-0.09M7.21M-6.83M14.24M
Change in Inventory (Quarter)
5.37M10.57M8.44M4.35M-1.55M-3.70M5.28M-4.67M-3.56M-4.29M-1.20M-0.49M-1.89M-4.41M-0.56M-2.66M5.08M2.37M4.62M0.59M
Change in Account Payables (Quarter)
1.40M3.35M-0.01M-0.76M1.23M6.92M3.28M-7.49M-0.22M1.92M-4.21M-1.52M-1.20M-4.88M5.71M0.71M3.19M-0.28M1.47M0.07M
Change in Accured Expenses (Quarter)
1.59M5.85M-3.62M4.46M4.69M-0.67M-3.72M6.61M-2.54M-0.46M-5.08M4.54M-1.31M9.72M-0.60M-8.06M3.97M11.30M-12.44M35.23M
Investing Activities
Capital Expenditures (Quarter)
6.94M8.09M12.78M31.97M40.64M16.46M11.82M-10.08M23.64M-24.61M1.51M0.60M0.96M2.00M2.14M-0.81M14.25M12.43M9.97M-4.43M
Sales of Property, Plant and Equipment (Quarter)
Acquisitions (Quarter)
0.48M8.16M
Change in Acquisitions & Divestments (Quarter)
112.00M32.00M12.00M18.68M44.80M25.00M27.50M78.00M31.00M18.24M24.00M6.00M2.00M21.91M21.32M7.65M21.16M20.55M5.00M
Cash from Investing Activities (Quarter)
104.58M23.91M-226.58M-13.29M4.16M2.78M-6.97M41.16M18.67M-2.25M4.17M-5.24M-0.71M-1.28M-1.54M-1.43M-9.40M-12.40M-9.93M-12.71M
Financing Activities
Other financing activities (Quarter)
-2.48M-2.62M-2.56M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
15.00M
Long-Term Debt Repayments (Quarter)
0.83M0.83M10.00M-11.56M3.12M
Change in Capital Stock
Shares Issued (Quarter)
314.75M-309.30M3.10M266.71M-265.05M265.06M0.60M0.25M0.35M0.17M0.95M1.32M2.92M1.92M2.95M0.77M1.83M3.79M0.30M1.79M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)
-0.77M1.57M-1.01M271.62M-1.31M1.24M-0.40M1.52M-0.66M0.44M-1.47M1.83M2.91M3.63M17.94M3.20M1.83M5.57M0.30M4.14M
Exchange Rate Effect (Quarter)
0.10M-0.13M0.08M0.02M-0.10M-0.32M0.27M0.07M-0.32M-0.05M0.12M-0.07M0.00M0.07M-0.05M0.10M-0.07M0.16M0.01M-0.01M
Change in Cash (Quarter)
75.95M-9.45M-274.16M216.00M-31.38M2.44M-61.17M-1.53M-5.72M-22.56M-20.16M-22.90M-4.18M-12.90M-5.07M-11.11M-9.04M-18.48M-34.44M-26.13M
Free Cash Flow (Quarter)
-34.90M-42.89M-59.44M-74.31M-74.77M-17.73M-65.89M-34.21M-47.05M3.91M-24.48M-20.03M-7.34M-17.32M-23.56M-12.18M-15.65M-24.24M-34.79M-13.12M
Net Cash Flow (Quarter)
75.85M-9.32M-274.25M215.98M-31.27M2.76M-61.44M-1.60M-5.40M-22.51M-20.28M-22.84M-4.18M-12.98M-5.02M-11.22M-8.97M-18.64M-34.45M-26.13M